Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Brett P Monia. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Brett P Monia har rapporterte beholdninger av handler i følgende selskaper:
| Verdipapir | Navn | Siste rapporterte høydepunkter |
|---|---|---|
| US:IONS / Ionis Pharmaceuticals, Inc. | Chief Executive Officer, Director | 180 009 |
| US:CGTX / Cognition Therapeutics, Inc. | Director | 48 500 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Brett P Monia. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp CGTX / Cognition Therapeutics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CGTX / Cognition Therapeutics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
| Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
|---|---|---|---|---|---|---|---|
| Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel CGTX / Cognition Therapeutics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CGTX / Cognition Therapeutics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
| Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
|---|---|---|---|---|---|---|---|
| Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internkjøp IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CGTX / Cognition Therapeutics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
| Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
|---|---|---|---|---|---|---|---|
| Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CGTX / Cognition Therapeutics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Brett P Monia som avslørt til Securies Exchange Comission (SEC).
| Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −59 699 | 180 009 | −24,90 | 61,06 | −3 645 394 | 10 991 872 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 27 568 | 239 708 | 13,00 | 32,60 | 898 717 | 7 814 481 | |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 31 316 | 212 140 | 17,32 | 32,60 | 1 020 902 | 6 915 764 | |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −127 500 | 180 824 | −41,35 | 60,13 | −7 667 047 | 10 873 616 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 42 030 | 308 324 | 15,78 | 37,58 | 1 579 487 | 11 586 816 | |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 615 | 266 294 | −5,87 | 59,12 | −982 262 | 15 743 035 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 102 900 | 282 909 | 57,16 | 53,77 | 5 532 933 | 15 212 017 | |
| 2025-09-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 189 | 180 009 | 0,11 | 27,71 | 5 237 | 4 988 049 | |
| 2025-08-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 432 | 179 820 | −1,33 | 45,00 | −109 440 | 8 091 900 |
| 2025-08-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 432 | 182 252 | 1,35 | 32,60 | 79 283 | 5 941 415 | |
| 2025-07-15 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 160 | 179 820 | −0,64 | 41,74 | −48 416 | 7 505 345 |
| 2025-06-23 |
|
4 | CGTX |
COGNITION THERAPEUTICS INC
Common Stock |
A - Award | 34 000 | 48 500 | 234,48 | ||||
| 2025-03-13 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −140 | 180 980 | −0,08 | 32,32 | −4 525 | 5 849 274 |
| 2025-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 437 | 181 120 | 0,24 | 28,21 | 12 328 | 5 109 667 | |
| 2025-02-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −38 843 | 180 683 | −17,69 | 31,65 | −1 229 463 | 5 718 996 |
| 2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −13 242 | 219 526 | −5,69 | 32,45 | −429 655 | 7 122 828 | |
| 2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 25 372 | 232 768 | 12,23 | ||||
| 2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −33 445 | 207 396 | −13,89 | 32,63 | −1 091 444 | 6 768 161 | |
| 2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 73 448 | 240 841 | 43,88 | ||||
| 2024-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 630 | 167 393 | −3,81 | 38,05 | −252 294 | 6 369 873 |
| 2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −23 907 | 173 732 | −12,10 | 49,37 | −1 180 348 | 8 577 583 | |
| 2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −23 907 | 173 732 | −12,10 | 49,37 | −1 180 348 | 8 577 583 | |
| 2024-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 140 | 174 023 | 0,08 | 38,64 | 5 410 | 6 724 423 | |
| 2024-06-11 |
|
4 | CGTX |
COGNITION THERAPEUTICS INC
Common Stock |
A - Award | 8 500 | 14 500 | 141,67 | ||||
| 2024-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 538 | 174 289 | 0,31 | 34,42 | 18 521 | 5 999 899 | |
| 2024-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −387 | 173 751 | −0,22 | 44,49 | −17 219 | 7 730 599 | |
| 2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −23 501 | 174 138 | −11,89 | 49,37 | −1 160 303 | 8 597 628 | |
| 2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 20 416 | 197 639 | 11,52 | ||||
| 2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 25 372 | 177 223 | 16,71 | ||||
| 2024-01-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 285 | 151 851 | −1,48 | 51,75 | −118 249 | 7 858 289 | |
| 2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −32 059 | 154 136 | −17,22 | 50,42 | −1 616 319 | 7 771 075 | |
| 2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 68 084 | 186 195 | 57,64 | ||||
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −17 500 | 118 111 | −12,90 | 49,29 | −862 577 | 5 821 703 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 500 | 135 611 | 14,82 | 47,34 | 828 450 | 6 419 825 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 500 | 118 111 | −5,22 | 49,64 | −322 643 | 5 862 723 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 500 | 124 611 | 5,50 | 47,34 | 307 710 | 5 899 085 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −9 140 | 118 111 | −7,18 | 50,19 | −458 709 | 5 927 637 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 9 140 | 127 251 | 7,74 | 47,34 | 432 688 | 6 024 062 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −14 860 | 118 111 | −11,18 | 49,21 | −731 310 | 5 812 632 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 860 | 132 971 | 12,58 | 47,34 | 703 472 | 6 294 847 | |
| 2023-10-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 770 | 118 111 | −3,09 | 46,00 | −173 420 | 5 433 106 |
| 2023-09-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 157 | 121 881 | 0,13 | 30,56 | 4 798 | 3 724 379 | |
| 2023-07-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 650 | 121 724 | −13,29 | 42,25 | −787 953 | 5 142 778 |
| 2023-06-13 |
|
4 | CGTX |
COGNITION THERAPEUTICS INC
Common Stock |
A - Award | 6 000 | 6 000 | |||||
| 2023-05-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 630 | 140 374 | −1,84 | 40,14 | −105 568 | 5 634 612 |
| 2023-05-24 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 301 | 143 004 | −1,58 | 40,13 | −92 339 | 5 738 751 |
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −24 651 | 145 305 | −14,50 | 40,69 | −1 003 153 | 5 913 071 | |
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 25 372 | 169 956 | 17,55 | ||||
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 17 210 | 144 584 | 13,51 | ||||
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 6 511 | 127 374 | 5,39 | ||||
| 2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −25 066 | 120 863 | −17,18 | 39,49 | −989 947 | 4 773 315 | |
| 2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 57 267 | 145 929 | 64,59 | ||||
| 2022-04-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −355 | 88 662 | −0,40 | 37,49 | −13 309 | 3 323 947 |
| 2022-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 621 | 89 017 | 0,70 | 28,37 | 17 620 | 2 525 679 | |
| 2022-01-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −8 032 | 88 396 | −8,33 | 31,44 | −252 526 | 2 779 170 | |
| 2022-01-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 14 004 | 96 428 | 16,99 | ||||
| 2022-01-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 2 194 | 82 424 | 2,73 | ||||
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −49 475 | 145 123 | −25,42 | ||||
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −19 714 | 80 230 | −19,73 | 30,12 | −593 786 | 2 416 528 | |
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 49 475 | 99 944 | 98,03 | ||||
| 2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 50 745 | 194 598 | 35,28 | ||||
| 2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 76 117 | 170 573 | 80,58 | ||||
| 2022-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 101 489 | 101 489 | |||||
| 2021-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 355 | 50 469 | 0,71 | 33,80 | 11 998 | 1 705 650 | |
| 2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −236 | 50 114 | −0,47 | 54,28 | −12 809 | 2 719 937 |
| 2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 247 | 50 350 | 0,49 | 44,54 | 11 001 | 2 242 589 | |
| 2021-02-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 306 | 50 103 | −2,54 | 60,69 | −79 261 | 3 040 751 | |
| 2021-02-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 2 634 | 51 409 | 5,40 | ||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −34 823 | 77 243 | −31,07 | ||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 77 447 | 77 447 | |||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 66 610 | 66 610 | |||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −14 927 | 48 775 | −23,43 | 61,28 | −914 727 | 2 988 932 | |
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 34 823 | 63 702 | 120,58 | ||||
| 2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 149 872 | 149 872 | |||||
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −23 840 | 0 | −100,00 | ||||
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 840 | 28 879 | −45,22 | 51,04 | −1 216 794 | 1 473 984 |
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 23 840 | 52 719 | 82,55 | 39,87 | 950 501 | 2 101 907 |
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −21 160 | 23 840 | −47,02 | ||||
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 160 | 28 879 | −42,29 | 51,32 | −1 085 931 | 1 482 070 |
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 21 160 | 50 039 | 73,27 | 39,87 | 843 649 | 1 995 055 |
| 2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −314 | 28 879 | −1,08 | 53,70 | −16 862 | 1 550 802 |
| 2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 236 | 29 193 | 0,82 | 44,46 | 10 491 | 1 297 775 | |
| 2020-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 314 | 28 957 | 1,10 | 43,16 | 13 553 | 1 249 871 | |
| 2020-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 148 454 | 148 454 | |||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −19 921 | 46 087 | −30,18 | ||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 17 009 | 17 009 | |||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 65 979 | 65 979 | |||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −7 563 | 28 643 | −20,89 | 62,06 | −469 360 | 1 777 585 | |
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 921 | 36 206 | 122,33 | ||||
| 2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 158 659 | 158 659 | |||||
| 2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −173 | 16 285 | −1,05 | 60,25 | −10 423 | 981 171 |
| 2019-11-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 776 | 16 458 | −25,98 | 60,01 | −346 618 | 987 645 |
| 2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −210 | 22 234 | −0,94 | 66,40 | −13 944 | 1 476 338 |
| 2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 173 | 22 444 | 0,78 | 45,70 | 7 907 | 1 025 792 | |
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −10 006 | 20 280 | −33,04 | ||||
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 45 728 | 45 728 | |||||
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −3 572 | 22 275 | −13,82 | 58,26 | −208 105 | 1 297 742 | |
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 006 | 25 847 | 63,17 | ||||
| 2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 102 900 | 102 900 | |||||
| 2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −214 | 15 837 | −1,33 | 53,50 | −11 449 | 847 280 |
| 2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 210 | 16 051 | 1,33 | 36,45 | 7 654 | 585 027 | |
| 2018-11-26 |
|
4 | IONIS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 34 000 | 0 | −100,00 | ||||
| 2018-11-26 |
|
4 | IONIS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −34 000 | 15 841 | −68,22 | 55,00 | −1 870 058 | 871 282 |
| 2018-11-26 |
|
4 | IONIS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 34 000 | 49 841 | 214,63 | 14,69 | 499 460 | 732 164 |
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 7 500 | 0 | −100,00 | ||||
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 8 993 | 0 | −100,00 | ||||
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 500 | 15 841 | −32,13 | 54,00 | −405 000 | 855 414 |
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 500 | 23 341 | 47,35 | 7,21 | 54 075 | 168 289 |
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 993 | 15 841 | −36,21 | 54,00 | −485 622 | 855 414 |
| 2018-08-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 993 | 24 834 | 56,77 | 7,25 | 65 199 | 180 046 |
| 2018-07-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −156 | 15 841 | −0,98 | 47,03 | −7 337 | 745 002 |
| 2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 214 | 15 997 | 1,36 | 35,42 | 7 580 | 566 606 | |
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 821 | 15 783 | −15,16 | 51,76 | −146 015 | 816 928 | |
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 985 | 10 703 | −39,49 | ||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 667 | 6 667 | |||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 12 916 | 12 916 | |||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 985 | 18 604 | 60,12 | ||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
| 2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 58 125 | 58 125 | |||||
| 2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −163 | 11 619 | −1,38 | 50,00 | −8 150 | 580 950 |
| 2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 156 | 11 782 | 1,34 | 42,76 | 6 670 | 503 739 | |
| 2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −309 | 11 626 | −2,59 | 51,35 | −15 867 | 596 995 |
| 2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 163 | 11 935 | 1,38 | 40,66 | 6 627 | 485 223 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −623 | 11 772 | −5,03 | 46,29 | −28 839 | 544 926 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −593 | 10 801 | −5,20 | 46,29 | −27 451 | 499 989 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −733 | 9 876 | −6,91 | 46,29 | −33 931 | 457 170 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −553 | 8 734 | −5,95 | 46,29 | −25 598 | 404 297 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 594 | 4 779 | −25,01 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 518 | 3 034 | −33,35 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 1 875 | −50,00 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 0 | −100,00 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 8 000 | 8 000 | |||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 594 | 12 395 | 14,76 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 518 | 11 394 | 15,37 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 10 609 | 21,47 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 9 287 | 17,98 | ||||
| 2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 48 000 | 48 000 | |||||
| 2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −309 | 7 872 | −3,78 | 48,60 | −15 017 | 382 579 |
| 2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 309 | 8 181 | 3,93 | 20,76 | 6 414 | 169 813 | |
| 2016-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −130 | 7 872 | −1,62 | 52,48 | −6 822 | 413 123 |
| 2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 309 | 8 002 | 4,02 | 20,76 | 6 414 | 166 098 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −604 | 7 693 | −7,28 | 41,46 | −25 041 | 318 939 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −747 | 6 779 | −9,93 | 41,46 | −30 969 | 281 044 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −564 | 5 651 | −9,07 | 41,46 | −23 382 | 234 281 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −83 | 4 800 | −1,70 | 41,47 | −3 442 | 199 032 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −210 | 4 675 | −4,30 | 41,46 | −8 707 | 193 840 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 518 | 4 552 | −25,01 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 3 750 | −33,33 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 1 415 | −50,00 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −208 | 0 | −100,00 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −527 | 0 | −100,00 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 373 | 6 373 | |||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 518 | 8 297 | 22,39 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 7 526 | 33,18 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 6 215 | 29,48 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 208 | 4 883 | 4,45 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 527 | 4 885 | 12,09 | ||||
| 2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 38 240 | 38 240 | |||||
| 2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −127 | 4 358 | −2,83 | 61,00 | −7 747 | 265 838 |
| 2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 130 | 4 485 | 2,99 | 47,71 | 6 202 | 213 982 | |
| 2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −198 | 4 355 | −4,35 | 56,30 | −11 147 | 245 186 |
| 2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 127 | 4 553 | 2,87 | 48,59 | 6 170 | 221 212 | |
| 2015-06-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 600 | 0 | −100,00 | ||||
| 2015-06-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 600 | 4 426 | −63,20 | 66,22 | −503 280 | 293 094 |
| 2015-06-10 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 600 | 12 026 | 171,71 | 10,29 | 78 204 | 123 748 |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −714 | 4 426 | −13,89 | 67,96 | −48 526 | 300 809 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 3 265 | −14,17 | 67,96 | −36 633 | 221 902 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −80 | 2 389 | −3,24 | 67,96 | −5 437 | 162 366 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −201 | 2 261 | −8,16 | 67,96 | −13 661 | 153 667 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 5 625 | −25,00 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 2 830 | −33,33 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −208 | 208 | −50,00 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −527 | 527 | −50,00 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 070 | 6 070 | |||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 5 140 | 57,43 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 3 804 | 59,23 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 208 | 2 469 | 9,20 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 527 | 2 462 | 27,24 | ||||
| 2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 36 423 | 36 423 | |||||
| 2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −76 | 1 935 | −3,78 | 62,75 | −4 769 | 121 421 |
| 2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 198 | 2 011 | 10,92 | 30,05 | 5 949 | 60 426 | |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 2 266 | −81,53 | ||||
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 5 245 | −74,09 | ||||
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 344 | 0 | −100,00 | ||||
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 813 | −84,65 | 38,14 | −381 440 | 69 155 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 813 | 551,57 | 7,25 | 72 500 | 85 644 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 1 813 | −89,22 | 38,14 | −572 160 | 69 155 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 16 813 | 827,36 | 10,29 | 154 350 | 173 006 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 344 | 1 813 | −56,39 | 38,14 | −89 410 | 69 155 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 344 | 4 157 | 129,29 | 11,27 | 26 417 | 46 849 |
| 2014-08-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −79 | 1 813 | −4,18 | 31,50 | −2 488 | 57 110 |
| 2014-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 76 | 1 892 | 4,19 | 30,20 | 2 295 | 57 139 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −202 | 1 816 | −10,01 | 47,08 | −9 510 | 85 497 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −80 | 1 490 | −5,10 | 47,08 | −3 766 | 70 150 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 1 362 | −28,35 | 47,08 | −25 376 | 64 123 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −528 | 1 054 | −33,38 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −208 | 416 | −33,33 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 4 245 | −25,00 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 500 | 7 500 | |||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 528 | 2 018 | 35,44 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 208 | 1 570 | 15,27 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 1 901 | 291,15 | ||||
| 2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 000 | 45 000 | |||||
| 2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −362 | 486 | −42,69 | 39,25 | −14 210 | 19 077 |
| 2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 79 | 848 | 10,27 | 24,20 | 1 912 | 20 521 | |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −18 281 | 2 344 | −88,64 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 281 | 769 | −95,96 | 35,89 | −656 105 | 27 599 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 18 281 | 19 050 | 2 377,24 | 11,27 | 206 027 | 214 694 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 875 | 20 625 | −8,33 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −22 500 | 0 | −100,00 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −625 | 0 | −100,00 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 875 | 769 | −70,92 | 33,35 | −62 531 | 25 646 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 875 | 2 644 | 243,82 | 11,27 | 21 131 | 29 798 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −22 500 | 769 | −96,70 | 33,35 | −750 375 | 25 646 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 22 500 | 23 269 | 2 925,88 | 14,47 | 325 575 | 336 702 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 769 | −86,67 | 33,35 | −166 750 | 25 646 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 769 | 650,20 | 14,65 | 73 250 | 84 516 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −625 | 769 | −44,84 | 33,35 | −20 844 | 25 646 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 625 | 1 394 | 81,27 | 15,75 | 9 844 | 21 956 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 769 | −96,30 | 33,96 | −679 200 | 26 115 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 20 769 | 2 600,78 | 15,38 | 307 600 | 319 427 |
| 2013-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 909 | 769 | −79,09 | 25,58 | −74 403 | 19 669 |
| 2013-08-28 | 3/A | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
2 909 | ||||||||
| 2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −215 | 5 842 | −3,55 | 28,69 | −6 169 | 167 636 |
| 2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 362 | 6 057 | 6,36 | 9,20 | 3 329 | 55 706 | |
| 2013-06-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 375 | 625 | −93,75 | ||||
| 2013-06-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 375 | 5 695 | −62,21 | 23,76 | −222 750 | 135 313 |
| 2013-06-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 375 | 15 070 | 164,62 | 15,75 | 147 656 | 237 352 |
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −17 000 | 0 | −100,00 | ||||
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 000 | 5 695 | −74,91 | 21,26 | −361 420 | 121 076 |
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 17 000 | 22 695 | 298,51 | 11,12 | 189 040 | 252 368 |
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 17 000 | −12,82 | ||||
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 5 695 | −30,51 | 21,25 | −53 125 | 121 019 |
| 2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 8 195 | 43,90 | 11,12 | 27 800 | 91 128 |
| 2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −18 240 | 0 | −100,00 | ||||
| 2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 240 | 5 695 | −76,21 | 16,86 | −307 599 | 96 040 |
| 2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 18 240 | 23 935 | 320,28 | 6,81 | 124 214 | 162 997 |
| 2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
| 2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 660 | 5 660 | |||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −95 | 5 695 | −1,64 | 14,00 | −1 330 | 79 730 | |
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −235 | 5 581 | −4,04 | 14,00 | −3 290 | 78 134 | |
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −209 | 624 | −25,09 | ||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −528 | 1 582 | −25,02 | ||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 209 | 5 790 | 3,74 | ||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 528 | 5 816 | 9,98 | ||||
| 2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −311 | 5 288 | −5,55 | 10,84 | −3 371 | 57 322 |
| 2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 215 | 5 599 | 3,99 | 8,87 | 1 908 | 49 686 | |
| 2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 031 | 0 | −100,00 | ||||
| 2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 031 | 5 384 | −69,08 | 15,25 | −183 473 | 82 106 |
| 2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 031 | 17 415 | 223,46 | 5,25 | 63 163 | 91 429 |
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −587 | 5 384 | −9,83 | 12,92 | −7 584 | 69 561 |
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 311 | 5 971 | 5,49 | 6,13 | 1 906 | 36 593 | |
| 2012-03-07 | 3/A | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
5 073 | ||||||||
| 2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 110 | 2 110 | |||||
| 2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 833 | 833 | |||||
| 2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 18 993 | 18 993 | |||||
| 2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
| 2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | −587 | 5 660 | −9,40 | 6,13 | −3 597 | 34 687 | |
| 2012-01-03 | 3 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
5 073 |
